Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 1.191.221.261.211.17

What is the latest Fixed Capital/Sales ratio of PIRAMAL PHARMA ?

The latest Fixed Capital/Sales ratio of PIRAMAL PHARMA is 1.19 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20251.19
Mar20241.22
Mar20231.26
Mar20221.21
Mar20211.17

How is Fixed Capital/Sales of PIRAMAL PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2025 1.19
-2.46
Mar2024 1.22
-3.17
Mar2023 1.26
4.13
Mar2022 1.21
3.42
Mar2021 1.17 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Fixed Capital/Sales ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹23,154.7 Cr 1.8% -7% -30.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,494.0 Cr -0.5% -1.9% -3% Stock Analytics
DIVIS LABORATORIES ₹170,514.0 Cr -0.9% -1.4% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,044.0 Cr 2% 2.4% 11.2% Stock Analytics
CIPLA ₹121,574.0 Cr -0.8% -1.2% 1.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,919.0 Cr -0.8% 1.7% -5.6% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

1.8%

-7%

-30.7%

SENSEX

0.7%

0.5%

9%


You may also like the below Video Courses